Clinical Trial Update: Glutamate for Metabolic Intervention in Coronary Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating glutamate for metabolic intervention in patients undergoing coronary surgery has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Glutamate (glutamate)

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Coronary Artery Bypass, Myocardial Ischemia | Phase 3 | Status: COMPLETED | Results posted: 2019-06-07